Nina Armagno, a Director at Rocket Lab USA Inc. (RKLB), reported multiple open-market sales totaling 27,314 shares of common stock on December 19, 2025, through a series of transactions at weighted average prices from $60.985 (200 shares) up to $70.1772 (12,446 shares), with total proceeds approximately $1.9 million based on average pricing around $68-70. These sales reduced her direct beneficial ownership from approximately 136,254 shares to 108,940 shares (an ~20% reduction). The transactions were explicitly made pursuant to a Rule 10b5-1 trading plan adopted by Armagno on September 19, 2025, indicating pre-planned, non-discretionary activity to avoid insider trading concerns. No prior transaction history or patterns are detailed in this filing, and there are no derivative securities involved. The sales occurred at elevated prices near recent highs, but the 10b5-1 context renders it neutral.

This 10b5-1 planned sale signals neutral insider confidence, as it reflects pre-committed diversification rather than opportunistic selling amid uncertainty. Directors often use such plans for routine liquidity without implying bearish views.